article thumbnail

STAT+: U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes

STAT

government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence. LONDON — A U.K. Mounjaro, also known as tirzepatide, has U.S.

Diabetes 248
article thumbnail

STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more

STAT

Enjoy, and see you soon… Western drug makers are talking to alternative suppliers in response to draft U.S. legislation seeking to restrict an important Chinese drug developer and manufacturer over national security concerns , The Financial Times explains. But be safe. The Biosecure Act would prohibit U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes. The post Is India capable of ensuring equitable access to biopharmaceuticals?

article thumbnail

6 Key Factors Influencing the Pharmaceutical Industry

PharmaShots

Social Factors Generation Health: This aspect is crucial as it corresponds to the layouts of drug development requirements based on the patient population of geography. Compared to the younger generation, the geriatric population requires more drugs.

article thumbnail

The Witty Answer to GSK’s Future

Pharmaceutical Technology

PT: Given recent problems with a safety scare over diabetes drug Avandia and GSK’s guidance for a fall in 2008 earnings, what do you envisage Witty’s top or first priorities will be in the new job? It has struck a large number of such deals in the last couple of years and we expect the number to continue to increase.